# The Combined Antibiotic Therapy for Carbapenem Resistant Klebsiella Pneumoniae

> **NCT03950544** · EARLY_PHASE1 · UNKNOWN · sponsor: **Shanghai 10th People's Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Antibiotic Resistant Infection

## Interventions

- **DRUG:** Fosfomycin
- **DRUG:** Tigecycline
- **DRUG:** Polymyxin B

## Key facts

- **NCT ID:** NCT03950544
- **Lead sponsor:** Shanghai 10th People's Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-01
- **Primary completion:** 2020-08-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2019-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03950544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03950544, "The Combined Antibiotic Therapy for Carbapenem Resistant Klebsiella Pneumoniae". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT03950544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*